Aequus Pharmaceuticals Inc Share Price Toronto S.E.
Equities
CA0076361033
Pharmaceuticals
Sales 2022 | 1.38M 1.01M 79.96M | Sales 2023 | 255K 187K 14.77M | Capitalization | 3.32M 2.44M 192M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.2M -174M | Net income 2023 | -2M -1.47M -116M | EV / Sales 2022 | 5.17 x |
Net Debt 2022 | 2.49M 1.83M 144M | Net Debt 2023 | 4.85M 3.56M 281M | EV / Sales 2023 | 32 x |
P/E ratio 2022 |
-1.45
x | P/E ratio 2023 |
-1.12
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.32% |
Managers | Title | Age | Since |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 31/12/12 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 02/01/13 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 21/07/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 02/01/13 |
Marc Lustig
BRD | Director/Board Member | 51 | 14/02/21 |
Director/Board Member | 54 | 17/12/14 |
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |